NCT04265963 2023-04-18
CD123-Targeted CAR-T Cell Therapy for Relapsed/Refractory Acute Myeloid Leukemia
Chongqing Precision Biotech Co., Ltd
Phase 1/2 Unknown
Chongqing Precision Biotech Co., Ltd
Chongqing Precision Biotech Co., Ltd
Shenzhen BinDeBio Ltd.
Chinese PLA General Hospital